| Masitinib studied in …STUDIED_INderived18 of 18show fewer |
|---|
| → studied in | NCT03761225Phase 3 · completed Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer · 18 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04333108Phase 3 · unknown Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment · 18 trials list this drug (0 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00812240Phase 3 · terminated Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) · 18 trials list this drug (0 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01694277Phase 3 · completed Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib · 18 trials list this drug (0 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02490488Phase 2/Phase 3 · completed Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients · 18 trials list this drug (0 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03556956Phase 2/Phase 3 · completed Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer · 18 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03766295Phase 3 · completed Masitinib Plus Gemcitabine in Pancreatic Cancer · 18 trials list this drug (0 active) | — | — | Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01280565Phase 3 · terminated Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit · 18 trials list this drug (0 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00814073Phase 3 · completed Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis · 18 trials list this drug (0 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866138Phase 2 · completed Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3 · 18 trials list this drug (0 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02605044Phase 3 · terminated Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer · 18 trials list this drug (0 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01470131Phase 3 · terminated A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma · 18 trials list this drug (0 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00789633Phase 3 · completed Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer · 18 trials list this drug (0 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02009423Phase 3 · terminated Masitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence · 18 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00831974Phase 2 · completed Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis · 18 trials list this drug (0 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00998751Phase 2 · completed Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST) · 18 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01506336Phase 2 · completed Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib · 18 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01266369Phase 2 · completed Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation · 18 trials list this drug (0 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |